Janssen Pharmaceuticals Inc.San Diego, CA, United States
Translational Science, J&J Innovative Medicine
2144: Pharmacodynamic Effects of Nipocalimab in Patients with Moderate to Severe Active Rheumatoid Arthritis (RA): Results from the Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2A IRIS-RA Study
Tuesday, November 14, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.